Insufficient scRNA-seq data for expression of CYP21A2 at single-cell level.
Insufficient scRNA-seq data for expression of CYP21A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1754.55 | 226 / 226 | 83% | 5.12 | 339 / 406 |
adrenal gland | 100% | 109739.52 | 258 / 258 | 53% | 324.21 | 121 / 230 |
kidney | 98% | 306.98 | 87 / 89 | 46% | 1.32 | 410 / 901 |
breast | 80% | 92.35 | 365 / 459 | 59% | 2.97 | 665 / 1118 |
thymus | 97% | 163.14 | 634 / 653 | 40% | 1.28 | 243 / 605 |
ovary | 100% | 257.68 | 180 / 180 | 28% | 0.86 | 122 / 430 |
brain | 79% | 72.57 | 2087 / 2642 | 47% | 1.37 | 330 / 705 |
uterus | 94% | 115.48 | 160 / 170 | 9% | 0.29 | 40 / 459 |
spleen | 99% | 329.62 | 239 / 241 | 0% | 0 | 0 / 0 |
prostate | 90% | 124.04 | 221 / 245 | 8% | 0.11 | 41 / 502 |
bladder | 90% | 124.62 | 19 / 21 | 3% | 0.05 | 13 / 504 |
intestine | 85% | 103.47 | 822 / 966 | 2% | 0.02 | 8 / 527 |
lung | 74% | 40.54 | 429 / 578 | 7% | 0.35 | 78 / 1155 |
esophagus | 75% | 86.05 | 1089 / 1445 | 3% | 0.10 | 6 / 183 |
adipose | 75% | 67.34 | 897 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 62% | 41.96 | 833 / 1335 | 0% | 0 | 0 / 0 |
stomach | 57% | 31.06 | 206 / 359 | 1% | 0.01 | 2 / 286 |
heart | 56% | 71.12 | 478 / 861 | 0% | 0 | 0 / 0 |
pancreas | 44% | 23.11 | 143 / 328 | 6% | 3.00 | 11 / 178 |
skin | 36% | 18.79 | 660 / 1809 | 1% | 2.06 | 6 / 472 |
peripheral blood | 20% | 11.61 | 190 / 929 | 0% | 0 | 0 / 0 |
muscle | 9% | 4.27 | 70 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006704 | Biological process | glucocorticoid biosynthetic process |
GO_0006705 | Biological process | mineralocorticoid biosynthetic process |
GO_0008202 | Biological process | steroid metabolic process |
GO_0016125 | Biological process | sterol metabolic process |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0106309 | Molecular function | progesterone 21-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0103069 | Molecular function | 17-hydroxyprogesterone 21-hydroxylase activity |
GO_0004509 | Molecular function | steroid 21-monooxygenase activity |
GO_0008395 | Molecular function | steroid hydroxylase activity |
GO_0020037 | Molecular function | heme binding |
GO_0005496 | Molecular function | steroid binding |
Gene name | CYP21A2 |
Protein name | 21-hydroxylase (EC 1.14.14.16) CYP21A2 protein Steroid 21-hydroxylase (EC 1.14.14.16) (21-OHase) (Cytochrome P-450c21) (Cytochrome P450 21) (Cytochrome P450 XXI) (Cytochrome P450-C21) 21-hydroxylase Mutant 21 hydroxylase (EC 1.14.99.10) Cytochrome P-450 c21 hydroxylase enzyme (EC 1.14.99.10) Steroid 21-hydroxylase (EC 1.14.99.10) Cytochrome P450 family 21 subfamily A member 2 Steroid 21 hydroxylase Steroid 21-hydroxylase (EC 1.14.14.16) (21-OHase) (Cytochrome P-450c21) (Cytochrome P450 21) (Cytochrome P450 XXI) (Cytochrome P450-C21) (Cytochrome P450-C21B) Steroid 21-hydroxylase Steroid 21-monooxygenase (EC 1.14.99.10) Truncated cytochrome P-450 c21 hydroxylase enzyme 21-hydroxylase (EC 1.14.99.10) |
Synonyms | CYP21B CYP21 |
Description | FUNCTION: A cytochrome P450 monooxygenase that plays a major role in adrenal steroidogenesis. Catalyzes the hydroxylation at C-21 of progesterone and 17alpha-hydroxyprogesterone to respectively form 11-deoxycorticosterone and 11-deoxycortisol, intermediate metabolites in the biosynthetic pathway of mineralocorticoids and glucocorticoids . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . . |
Accessions | E7EN87 C7DTY4 ENST00000434026.2 [P08686-2] C7DU17 ENST00000448478.6 [P08686-1] B2D081 C7DTW5 E7EVC0 B2YHV7 A0A4P2UU84 ENST00000471671.4 Q1EM52 A0A4P2V2R5 Q1H8Y2 A0A023J7R6 C7DU04 ENST00000383321.4 [P08686-2] ENST00000452708.2 C7DTW8 Q1H8Y3 C7DU10 C7DTV1 ENST00000448314.6 Q1H8Y4 A0A1L6Z3L5 Q1EM51 E9M5C7 C7DTU9 A0A1P8SW53 K9LHU7 B6VE01 B8YJC6 C7DTY1 C7DU00 A0A4P2UTF4 Q08AG9 U5YU50 B2YHV6 C7DTW2 C7DTW4 K9LII7 E9M5C8 A0A1P8SW43 V5WC48 A9UF27 Q1H8Y5 K9LHV3 K9LHV1 ENST00000448877.2 C7DTX2 E9M5C9 A0A1L6Z3K9 ENST00000456152.6 [P08686-1] A0A0G2JJF2 ENST00000435122.3 [P08686-2] A9UF28 P08686 K9LHU1 A8W368 A6ZI22 A0A1P8SW42 C7DTX7 E7ERT7 ENST00000644719.2 [P08686-1] C7DU02 A1A5B1 E9M5D0 A0A2U7NZY9 C7DTV0 E9M5D1 F8WBR4 C7DTV6 C6K7H0 K9LII5 K9LIR4 C7DTY5 C6K7H1 C7DTZ2 ENST00000452386.2 [P08686-2] A5HSJ6 ENST00000478281.5 C7DTX8 ENST00000383322.8 [P08686-1] Q2UVX6 C7DTW1 Q2UVX5 A0A1U9IMX4 Q1EM53 Q16742 ENST00000466779.5 A0A1P8SW33 C7DTX9 ENST00000469053.5 ENST00000436607.6 |